Munafa Stock Market Course + Intraday & FNO calls 
Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Intellia Therapeutics (NTLA)
Technical Analysis Report for USA stock NTLA Intellia Therapeutics. Dated: 05 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock NTLA Intellia Therapeutics then click here. or read Experts views on Intellia Therapeutics or Forecast & share price targets of Intellia Therapeutics
Intellia Therapeutics Opened at 9.59 and Closed at: 9.61, which is -1.46% of previous session's close. It moved within a range of 9.36 and 9.66
The session was a Bullish session with an average volume of 4030300, which is -18.06% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
Support for tomorrow is 9.49 and resistance for tomorrow is 9.79
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 9.43, 9.24 resistance for tomorrow's hourly charts is 9.73, 9.84
10 Day SMA for Intellia Therapeutics (NTLA) is 8.76 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Intellia Therapeutics (NTLA) is 8.85 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Intellia Therapeutics (NTLA) is 15.49 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 13.88 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Intellia Therapeutics is 11.35 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Intellia Therapeutics is at 8.85 and 200 DMA is at 11.35, while 50 DMA and 100 DMA are at 15.49 and 13.88 respectively
Intellia Therapeutics (NTLA) moving average of 20 SMA is at 8.85 and 20 EMA is at 9.97
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Fri Dec | 9.61 | 8.85 | 9.97 |
| 04 Thu Dec | 9.75 | 8.99 | 10.01 |
| 03 Wed Dec | 9.06 | 9.18 | 10.04 |
| 02 Tue Dec | 8.11 | 9.34 | 10.14 |
| 01 Mon Dec | 8.42 | 9.56 | 10.35 |
| 28 Fri Nov | 8.99 | 9.77 | 10.55 |
Intellia Therapeutics (NTLA) moving average of 50 SMA is at 15.49 and 50 EMA is at 12.5
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Fri Dec | 9.61 | 15.49 | 12.5 |
| 04 Thu Dec | 9.75 | 15.63 | 12.62 |
| 03 Wed Dec | 9.06 | 15.79 | 12.74 |
| 02 Tue Dec | 8.11 | 15.95 | 12.89 |
| 01 Mon Dec | 8.42 | 16.14 | 13.09 |
| 28 Fri Nov | 8.99 | 16.28 | 13.28 |
Intellia Therapeutics (NTLA) moving average of 100 SMA is at 13.88 and 100 EMA is at 13.07
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Fri Dec | 9.61 | 13.88 | 13.07 |
| 04 Thu Dec | 9.75 | 13.9 | 13.14 |
| 03 Wed Dec | 9.06 | 13.92 | 13.21 |
| 02 Tue Dec | 8.11 | 13.95 | 13.29 |
| 01 Mon Dec | 8.42 | 13.98 | 13.39 |
| 28 Fri Nov | 8.99 | 14.02 | 13.49 |
Intellia Therapeutics (NTLA) moving average of 200 SMA is at 11.35 and 200 EMA is at 13.35
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Fri Dec | 9.61 | 11.35 | 13.35 |
| 04 Thu Dec | 9.75 | 11.36 | 13.39 |
| 03 Wed Dec | 9.06 | 11.37 | 13.43 |
| 02 Tue Dec | 8.11 | 11.38 | 13.47 |
| 01 Mon Dec | 8.42 | 11.4 | 13.52 |
| 28 Fri Nov | 8.99 | 11.4 | 13.57 |
Qiagen N has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Qiagen N, about 6.74% more returns!
Intellia Therapeutics has performed better than Cigna Corporation in short term. Holding Intellia Therapeutics could be a better choice for now!
Bristol Myers has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Bristol Myers, about 10.49% more returns!
Viking Therapeutics has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Viking Therapeutics, about 3.62% more returns!
Intellia Therapeutics has performed better than Vericel Corporation in short term. Holding Intellia Therapeutics could be a better choice for now!
Syndax Pharmaceuticals has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Syndax Pharmaceuticals, about 33.95% more returns!
Soleno Therapeutics has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Soleno Therapeutics, about 6.53% more returns!
Intellia Therapeutics has performed better than Prophase Labs in short term. Holding Intellia Therapeutics could be a better choice for now!
Neurocrine Biosciences has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Neurocrine Biosciences, about 0.9% more returns!
Mesoblast has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Mesoblast, about 21.15% more returns!
Lipocine Inc has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Lipocine Inc, about 22.86% more returns!
Intellia Therapeutics has performed better than Lemaitre Vascular in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Iterum Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!
Diamedica Therapeutics has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Diamedica Therapeutics, about 47.15% more returns!
Intellia Therapeutics has performed better than Citius Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!
Curis Inc has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Curis Inc, about 1.89% more returns!
Avadel Pharmaceuticals has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Avadel Pharmaceuticals, about 12.96% more returns!
Intellia Therapeutics has performed better than Atossa Genetics in short term. Holding Intellia Therapeutics could be a better choice for now!
Aclaris Therapeutics has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Aclaris Therapeutics, about 24.7% more returns!
Intellia Therapeutics Technical analysis of indicators
Price action analysis of Intellia Therapeutics (NTLA) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Intellia Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Intellia Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Intellia Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term
MRSI is in negative zone. This is the SELL zone
Stock of Intellia Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.78 and Intellia Therapeutics NTLA stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Intellia Therapeutics NTLA stock. Volume based technical analysis of Intellia Therapeutics NTLA stock is negative.
Intellia Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock NTLA Intellia Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NTLA Experts View which covers a lot of information including buying and selling signals
NTLA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Intellia Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
